期刊文献+

反义核酸封闭H-2K^d基因对鼠淋巴因子激活杀伤细胞活性的影响 被引量:6

Silence of H-2K^d gene by antisense oligonucleotides complementary has effect on the cytotoxicity of LAK cells in mouse
原文传递
导出
摘要 目的 观察反义寡核苷酸封闭鼠淋巴细胞H-2Kd基因后,对其表达的影响及淋巴因子激活杀伤细胞(LAK)的活性改变,探讨淋巴细胞Ⅰ类主要组织相容性抗原(MHC-Ⅰ)在肿瘤免疫中的作用。方法 将人工合成的H-2Kd起始区反义寡核苷酸作用于小鼠脾LAK,流式细胞仪检测作用前后H-2Kd的表达率。噻唑蓝法检测H-2Kd表达降低的LAK对肿瘤杀伤活性。结果 反义寡核苷酸(15μmoL/l)组H-2Kd蛋白的表达率由90.1%±4.4%下降至79.8%±2.5%(P<0.01),H-2Kd降低的LAK杀伤活性明显降低,对K562的杀伤活性由82.3%±3.1%降到60.2%±6.7%(P<0.01),对H22细胞株的杀伤活性由67.4%±2.8%降到53.2%±8.1%(P<0.01)。结论 反义寡核苷酸能够抑制小鼠LAK表面H-2Kd的表达,但不影响LAK增殖活性,因而可导致鼠LAK对同种及异种肿瘤细胞的杀伤活性降低。 Objective In order to understand the effect of MHC-I of host lymphocyte in tumor immune, observing proliferation and cytotoxicity of BALB/c spleen LAK cells which with silent the gene by H-2Kd antisense oligonucleotides ( ASON) . Methods ASON complementary to initiator of H-2Kd was applied to spleen LAK cells. The H-2Kd gene expression of treated and control cells were examined by Flow cytometry(FCM). The proliferation and cytotoxicity for H22 and K562 cell lines were evaluated in vitro with MTT colorimetric assay. Results ASON (15μmol/l) treatment for H-2Kd gene reduced targeted protein from 90. 1%±4.4% to 79. 8% ± 2. 5% (P < 0. 01). The cytotoxicity for K562 reduced from 82. 3% ± 3. 1% to 60. 2% ± 6. 7% ( P < 0. 01), and that for H22 cells reduced from 67.4% ± 2. 8% to 53. 2%± 8. 1% (P< 0. 01 ). Conclusion The reduced expression level of H-2Kd gene silenced by ASON didn't inhibit proliferation in LAK cells, but reduced the cytotoxicity for H22 and K562 cells significantly.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2004年第5期327-329,共3页 Chinese Journal of Laboratory Medicine
基金 山东省科技厅重点课题资助项目(1995BB1CJA6)
关键词 反义核酸 H-2K^d基因 淋巴因子激活杀伤细胞 活性 肿瘤免疫 Antisense oligonucleotides Lymphokine Kill cell
  • 相关文献

参考文献6

  • 1Wang CX, Zou X, wang LF, et al. Expression of MHC antigen in tissues and peripheral blood lymphocytes of patients with gastric carcinoma. J Tumor Marker Oncol,2003, 18:72-79.
  • 2Le MC,Cogne M,Drouet,M,et al.HLA-A and HLA-B transcripition decrease with aging in peripheral blood lymphocytes.Clin Exp Immunol,2001,125:245-250.
  • 3杨晓静,邹雄,王传新,邹明瑾,张锑.外周血单个核细胞中乙型肝炎病毒感染与细胞表面HLA-I类抗原表达的关系探讨[J].中华医学杂志,2002,82(21):1499-1500. 被引量:7
  • 4邹雄,徐从高.MHC和肿瘤转移[J].国外医学(肿瘤学分册),1997,24(5):289-291. 被引量:4
  • 5邹雄 张利宁.分子免疫学与临床[M].济南:山东科技出版社,2002.283-300.
  • 6杨镇.肿瘤免疫学[M].武汉:湖北科学技术出版社,1999.37-39.

二级参考文献2

共引文献11

同被引文献26

  • 1邹雄.淋巴细胞表面MHC-Ⅰ在机体免疫中的作用探讨[J].诊断学理论与实践,2005,4(3):185-187. 被引量:3
  • 2彭建明,李金明.定量PCR测定数据处理数学模型研究进展[J].国外医学(临床生物化学与检验学分册),2005,26(7):449-451. 被引量:4
  • 3WANG Chuan-xin,WANG Jin-feng,LIU Min,ZOU Xiong,YU Xiu-ping,YANG Xiao-jing,ZHENG Gui-xi.Expression of HLA class I and II on peripheral blood lymphocytes in HBV infection[J].Chinese Medical Journal,2006(9):753-756. 被引量:6
  • 4张义,邹雄,杨晓静,李晓丽,赵胜梅,高艳景.淋巴细胞HLA—B表达与胃癌分化转移的关系[J].中华肿瘤杂志,2007,29(1):49-52. 被引量:8
  • 5Sadanaga N, Kuwano H, Watanabe M, et al. Local immune response to tumor invasion in esophageal squamouw cell ca-rcinoma. The expression of human leukocyte antigen- DR and lymphocyte infil- tration[J]. Cancer, 1994, 74(2) :586-591.
  • 6Alessandro S, Robert C, John F. HLA expression in cancer: Implications for T cell 2 based immunotherapy[ J]. Immunogenetics, 2001, 53 : 255-263.
  • 7Browning M, Dunnion D. Ilia and cancer: Implications for cancer immunotherapy and Vaccination[ J]. Eur J Immunogenet, 1997, 24(4) :293-312/
  • 8Jimenez P, Canton J, Collado A, et. al. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors[J]. Int J Cancer, 1999, 83(1):91-95.
  • 9萨姆布鲁克 D.W.拉塞尔.分子克隆实验指南.北京:科学出版社,2002.518-522.
  • 10Pfaffl MW,Horgan GW,Dempfle L.Relative expression software tool (REST) for group-wise comparision and statistical analysis of relative expression results in ream-time PCR.Nucleic Acids Res,2002,30:e36.

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部